Only EPHX2 has been identified as a differentially expressed lipid metabolism-related gene responsible for immune dysfunction in sepsis [40] and speculated as a potential biomarker for sepsis-associated acute kidney injury (SA-AKI), exhibiting decreased expression in cases of SA-AKI [41], which aligns with our findings. This evidence concerns the gene EPHX2 and Sepsis.